Lloyd H Dean
CIK 1332215 · last filed 2026-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WFC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CHICAGO, IL 60607
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MCD | Director | 462 | $248.72 | $115.0K | $0 | 43 | 2026-10-02 |
| SGRY | Director | 11,670 | $23.20 | $270.7K | $0 | 1 | 2026-06-09 |
| PGNY | Director | 26,519 | $27.90 | $739.9K | $0 | 7 | 2026-05-26 |
| Bolt Projects Holdings, Inc. (BSLKW) Delisted | Director | 35,000 | $0.02 | $746 | $0 | 1 | 2024-08-15 |
| WFC | Director | 13,272 | $82.66 | $1.10M | -$395.3K | 59 | 2018-04-03 |
| NCI | Director | 575 | $0.83 | $478 | $0 | 2 | 2016-05-19 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | 5,140 | — | — | $121.1K | 9 | 2014-01-03 |
Recent Filings · Page 11 of 13
122 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-04-04 | WFC | Grant (A) | — | $0 | EDGAR |
| 2011-03-03 | WFC | Exer (M) | +7,348 | $232.6K | EDGAR |
| 2011-01-04 | WFC | Grant (A) | — | $0 | EDGAR |
| 2010-11-03 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Grant (A) | +21,000 | $98.7K | EDGAR |
| 2010-10-04 | WFC | Grant (A) | — | $0 | EDGAR |
| 2010-07-02 | WFC | Grant (A) | — | $0 | EDGAR |
| 2010-04-28 | WFC | Grant (A) | — | $0 | EDGAR |
| 2010-04-02 | WFC | Grant (A) | — | $0 | EDGAR |
| 2010-03-02 | WFC | Exer (M) | +13,772 | $376.7K | EDGAR |
| 2010-01-05 | WFC | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.